Clearing of psoriasis in a nephrectomized patient by monotherapy with TNF-α antagonist, infliximab, with follow-up of 1 year

Biologic Therapeutics in the Treatment of Psoriasis. Part 1: Review

“…59 Current data demonstrate that infliximab is highly efficacious in the treatment of psoriasis (see Table 3). 63 There have been cases reported in the literature in which plaque psoriasis [64][65][66] and pustular psoriasis [67][68][69] were successfully treated with infliximab, with clinical improvement reported in one case as early as 3 days following infliximab infusion. 61 Open-label and phase II studies have produced similar results, with rapid and significant clearing of psoriatic plaques (see Table 3).…”